Role of endoscopy in the investigation of upper gastrointestinal symptoms in HIV-infected patients

Canadian Journal of Gastroenterology

Volumn 13, Issue 4, 1999, Pages 305-310

  Wilcox, C Mel ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

Acquired immunodeficiency syndrome; Endoscopy; Human immunodeficiency virus

Indexed keywords

ANTIFUNGAL AGENT; CD4 ANTIGEN;

ABDOMINAL PAIN; ACQUIRED IMMUNE DEFICIENCY SYNDROME; CLINICAL FEATURE; DIARRHEA; DIGESTIVE SYSTEM HEMORRHAGE; DIGESTIVE TRACT ENDOSCOPY; DISEASE PREDISPOSITION; ESOPHAGUS; GASTROINTESTINAL SYMPTOM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; INTESTINE BIOPSY; LYMPHOCYTE COUNT; MYCOSIS; NAUSEA; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; REVIEW; VOMITING;

EID: 0032983530     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/1999/418170     Document Type: Review

References (49)

1. Palella FJ Jr, Melaney KM, Moorman AC, Loveless MO, Fuhrer J. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998;338:853-60.
2. Gallant JE, Moore RD, Richman DD, Keruly J, Chaisson RE. Incidence and natural history of cytomegalovirus disease in patients with the advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group. J Infect Dis 1992;166:1223-7.
3. Mellors JW, Munoz A, Giorgi JV, et al. Plasma viral load and CD4 lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 1997;126:946-54.
4. Vlahov D, Graham N, Hoover D, et al. Prognostic indicators for AIDS and infectious disease death in HIV-infected injection drug users. JAMA 1998;279:35-40.
5. Bashir RM, Wilcox CM. Symptom-specific use of upper gastrointestinal endoscopy in human immunodeficiency virus-infected patients yields high dividends. J Clin Gastroenterol 1996;23:292-8.
6. Moore RD, Chaisson RE. Natural history of opportunistic disease in an HIV-infected urban clinical cohort. Ann Intern Med 1996;124:633-42.
7. Mocroft A, Youle M, Phillips AN, et al. The incidence of AIDS-defining illnesses in 4883 patients with human immunodeficiency virus infection. Royal Free/Chelsea and Westminster Hospitals Collaborative Group. Arch Intern Med 1998;158:491-7.
8. Wilcox CM, Rabeneck L, Friedman S. AGA technical review: malnutrition and cachexia, chronic diarrhea, and hepatobiliary disease in patients with human immunodeficiency virus infection. Gastroenterology 1996;111:1724-52.
9. Wilcox CM. Esophageal disease in the acquired immunodeficiency syndrome: etiology, diagnosis, and management. Am J Med 1992;92:412-21.
10. Connolly GM, Hawkins D, Harcourt-Webster JN, Parsons PA, Husain OA, Gazzard BG. Oesophageal symptoms, their causes, treatment, and prognosis in patients with the acquired immune deficiency syndrome. Gut 1989;30:1033-9.
11. Bonacini M, Young T, Laine L. The causes of esophageal symptoms in human immunodeficiency virus infection: A prospective study of 110 patients. Arch Intern Med 1991;151:1567-72.
12. Wilcox CM, Alexander LN, Clark WS, Thompson SE III. Fluconazole compared with endoscopy for human immunodeficiency virus-infected patients with esophageal symptoms. Gastroenterology 1996;110:1803-9.
13. Wilcox CM. Evaluation of a technique to evaluate the underlying mucosa in patients with AIDS and severe Candida esophagitis. Gastrointest Endosc 1995;42:360-3.
14. Wilcox CM, Schwartz DA, Clark WS. Esophageal ulceration in human immunodeficiency virus infection: Causes, response to therapy, and long-term outcome. Ann Intern Med 1995;122:143-9.
15. Dieterich DT, Wilcox CM. Diagnosis and treatment of esophageal diseases associated with HIV-infection. Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol 1996;91:2265-8.
16. Wilcox CM. Time course of clinical response to fluconazole for Candida oesphagitis in AIDS. Aliment Pharmacol Ther 1994;8:347-50.
17. Gil A, Lavilla P, Valencia E, et al. Safety and efficacy of fluconazole treatment for Candida oesophagitis in AIDS. Postgrad Med J 1991;67:548-52.
18. Rabeneck L, Laine L. Esophageal candidiasis in patients infected with the human immunodeficiency virus. A decision analysis to assess cost-effectiveness of alternative management strategies. Arch Intern Med 1994;154:2705-10.
19. Wilcox CM, Straub RF, Clark WS. Prospective evaluation of oropharyngeal findings in human immunodeficiency virus-infected patients with esophageal ulcer. Am J Gastroenterol 1995;90:1938-41.
20. Barbara G, Barbarini G, Calderon W, Grisorio B, Alcini P, Di Lorenzo G. Fluconazole versus itraconazole for candida esophagitis in acquired immunodeficiency syndrome. Gastroenterology 1996;111:1169-77.
21. Laine L, Dretler RH, Conteas CN, et al. Fluconazole compared with ketoconazole for the treatment of Candida esophagitis in AIDS. A randomized trial. Ann Intern Med 1992;117:655-60.
22. Wilcox CM, Darouiche RO, Laine L, Moskovitz BL, Mallegol I, Wu J. A randomized, double-blind comparison of itraconazole oral solution and fluconazole tablets in the treatment of esophageal candidiasis. J Infect Dis 1997;176:227-32.
23. Wilcox CM, Mönkemüller KE. Review article: the therapy of gastrointestinal infections associated with the acquired immunodeficiency syndrome. Aliment Pharmacol Ther 1997;11:425-43.
24. Wilcox CM, Straub RF, Alexander LN, Clark WS. Etiology of esophageal disease in human immunodeficiency virus infected patients who fail antifungal therapy. Am J Med 1996;101:599-604.
25. Wilcox CM, Schwartz DA. Comparison of two corticosteroid regimens for the treatment of HIV-associated idiopathic esophageal ulcer. Am J Gastroenterol 1994;89:2163-7.
26. Alexander LN, Wilcox CM. A prospective trial of thalidomide for the treatment of HIV-associated idiopathic esophageal ulcers. AIDS Res Hum Retroviruses 1997;13:301-4.
27. Connolly GM, Forbes A, Gleeson JA, Gazzard BG. Short communication investigation of upper gastrointestinal symptoms in patients with AIDS. AIDS 1989;3:453-6.
28. Baehr PH, McDonald GB. Esophageal infections: risk factors, presentation, diagnosis, and treatment. Gastroenterology 1994;106:509-32.
29. Wilcox CM, Straub RF, Schwartz DA. A prospective evaluation of biopsy number for the diagnosis of viral esophagitis in patients with HIV infection and esophageal ulcer. Gastrointest Endosc 1996;44:587-93.
30. Marano BJ, Smith F, Bonanno CA. Helicobacter pylori prevalance in acquired immunodeficiency syndrome. Am J Gastroenterol 1993;88:687-90.
31. Battan R, Raviglione MC, Palagiano A, et al. Helicobactor pylori infection in patients with acquired immune deficiency syndrome. Am J Gastroenterol 1990;85:1576-9.
32. Nielsen H, Anderson LP. Serodiagnosis of Helicobocter pylori infection in patients with human immunodeficiency virus infection. APMIS 1995;103:689-92.
33. Edwards PD, Carrick J, Turner J, Lee A, Mitchell H, Cooper DA. Helicobacter priori-associated gastritis is rare in AIDS: Antibiotic effect or consequences of immunodeficiency? Am J Gastroenterol 1991;86:1761-4.
34. Lake-Bakaar G, Quadros E, Beidas S, Elsakr M, Tom W, Wilson DE. Gastric secretory failure in patients with the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1988;109:502-4.
35. Welage LS, Carver PL, Revankar S, Pierson C, Kauffman CA. Alterations in gastric acidity in patients infected with human immunodeficiency virus. Clin Infect Dis 1995;21:1431-8.
36. Sundar K, Suarez M, Banogoon PE, Shapiro JM. Zidovudine-induced fatal lactic acidosis and hepatic failure in patients with acquired immunodeficiency syndrome: Report of two patients and review of the literature. Crit Care Med 1997;25:1425-30.
37. Blanshard C, Francis N, Gazzard BG. Investigation of chronic diarrhea in acquired immunodeficiency syndrome. A prospective study of 155 patients. Gut 1996;39:824-32.
38. Connolly GM, Forbes A, Gazzard BG. Investigation of seemingly pathogen-negative diarrhea in patients infected with HIV1. Gut 1990;31:886-9.
39. Wilcox CM, Schwartz DA, Cotsonis GA, Thompson WE III. Evaluation of chronic unexplained diarrhea in human immunodeficiency virus infection: determination of the best diagnostic approach. Gastroenterology 1996;110:30-7.
40. Bown JW, Savides TJ, Mathews C, Isenberg J, Behling C, Lyche KD. Diagnostic yield of duodenal biopsy and aspirate in AIDS-associated diarrhea. Am J Gastroenterol 1996;91:2289-92.
41. Bini EJ, Cohen J. Diagnostic yield and cost-effectiveness of endoscopy in chronic human immunodeficiency virus-related diarrhea. Gastrointest Endosc 1998;48:354-61.
42. Gray JR, Rabeneck L. Atypical mycobacterial infection of the gastrointestinal tract in AIDS patients. Am J Gastroenterol 1989;84:1521-4.
43. Chalasani N, Lazenby AJ, Wilcox CM. Unusual endoscopic features of gastric and duodenal cryptosporidiosis in AIDS. Gastrointest Endosc 1997;45:525-7.
44. Chalasani N, Wilcox CM, Hunter HT, Schwartz DA. Endoscopic features of gastroduodenal cryptococcosis in AIDS. Gastrointest Endosc 1997;45:315-7.
45. Parente F, Cernuschi M, Antinori S, et al. Severe abdominal pain in patients with AIDS: Frequency, clinical aspects, causes and outcome. Scand J Gastroenterol 1994;29:511-5.
46. Thuluvath PJ, Connolly CM, Forbes A, Gazzard BG. Abdominal pain in HIV infection. Q J Med 1991;78:275-85.
47. Parente F, Chernuschi M, Valsecchi M, et al. Acute upper gastrointestinal bleeding in patients with AIDS: A relatively uncommon condition associated with reduced survival. Gut 1991;32:987-90.
48. Cappell MS, Geller AJ. The high mortality of gastrointestinal bleeding in HIV-seropositive patients: A multivariate analysis of risk factors and warning signs of mortality in 50 consecutive patients. Am J Gastroenterology 1992;87:815-24.
49. Chalasani N, Wilcox CM. Etiology and outcome of lower gastrointestinal bleeding in patients with AIDS. Am J Gastroenterol 1998;93:175-8.